Skip to main content
Clinical Trials/TCTR20230831001
TCTR20230831001
Active, not recruiting
Not Applicable

DNA methylation in Follicular fluid and plasma derived exosome in polycystic ovary syndrome

Program Management Unit for Human Resources & Institutional Development,Research and Innovation (PMU-B)0 sites20 target enrollmentAugust 31, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Polycystic ovary syndrome (PCOS) in infertile women who seeking infertility treatment with in vitro fertilization (IVF)
Sponsor
Program Management Unit for Human Resources & Institutional Development,Research and Innovation (PMU-B)
Enrollment
20
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 31, 2023
End Date
May 31, 2024
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
Program Management Unit for Human Resources & Institutional Development,Research and Innovation (PMU-B)

Eligibility Criteria

Inclusion Criteria

  • 1\. Female age 18\-42 year old
  • 2\. Diagnosed as PCOS according to International Evidence\-Based Guideline for the Assessment and Management of Polycystic ovary syndrome 2018

Exclusion Criteria

  • 1\. Diagnosed as any cancer
  • 2\. Diagnosed as endometriosis
  • 3\. Diagnosed as PCOS mimicking diseases such as Cushing syndrome, Adult onset adrenal hyperplasia, thyroid disease

Outcomes

Primary Outcomes

Not specified

Similar Trials